21 Mar 2017
QT Vascular Ltd. - Capital commitment agreement with GEM Global Yield Fund LLC SCS
Danny Lim and Caitlin Huang have advised QT Vascular Ltd., which is listed on the SGX-ST Catalist, in its S$10 million capital commitment agreement with GEM Global Yield Fund LLC SCS ("Investor") whereby the Investor agreed to grant the company an option to require the Investor to subscribe for new shares of the company, for up to an aggregate of S$10 million or a maximum of 178 million new shares, and for the Company to issue to the Investor warrants of up to 35 million new shares with an exercise price of S$0.10 each to raise up to S$3.5 million. The Investor also agrees to enter into an additional capital commitment of S$10 million on the same terms within a period of 6 calendar months, as and when required by the Company in its absolute discretion.
QT Vascular is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. It collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.